These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11543682)

  • 21. Synthesis, characterization, and biological evaluation of technetium(III) complexes with tridentate/bidentate S,E,S/P,S coordination (E = O, N(CH(3)), S): a novel approach to robust technetium chelates suitable for linking the metal to biomolecules.
    Pietzsch HJ; Seifert S; Syhre R; Tisato F; Refosco F; Leibnitz P; Spies H
    Bioconjug Chem; 2003; 14(1):136-43. PubMed ID: 12526702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dicarboxylate diamide dimercaptide (N2S2) technetium-99m complexes: synthesis and biological evaluation as potential renal radiopharmaceuticals.
    Canney DJ; Billings J; Francesconi LC; Guo YZ; Haggerty BS; Rheingold AL; Kung HF
    J Med Chem; 1993 Apr; 36(8):1032-40. PubMed ID: 8478903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transition metal chemistry of main group hydrazides, Part 14: Evaluation of new Tc-99m chelates of thiol functionalized phosphorus hydrazides.
    Singh PR; Lusiak P; Volkert WA; Ketring AR; Holmes RA; Katti KV
    Nucl Med Biol; 1995 Oct; 22(7):849-57. PubMed ID: 8547882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, biological and autoradiographic evaluation of a novel Tc-99m radioligand derived from WAY 100635 with high affinity for the 5-HT(1A) receptor and the alpha1-adrenergic receptor.
    Heimbold I; Drews A; Kretzschmar M; Varnäs K; Hall H; Halldin C; Syhre R; Kraus W; Pietzsch HJ; Seifert S; Brust P; Johannsen B
    Nucl Med Biol; 2002 May; 29(4):375-87. PubMed ID: 12031872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Organometallic 99mTc(III) '4 + 1' bombesin(7-14) conjugates: synthesis, radiolabeling, and in vitro/in vivo studies.
    Kunstler JU; Veerendra B; Figueroa SD; Sieckman GL; Rold TL; Hoffman TJ; Smith CJ; Pietzsch HJ
    Bioconjug Chem; 2007; 18(5):1651-61. PubMed ID: 17663527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, characterization, and biological evaluation of neutral nitrido technetium(V) mixed ligand complexes containing dithiolates and aminodiphosphines. A novel system for linking technetium to biomolecules.
    Bolzati C; Benini E; Cazzola E; Jung C; Tisato F; Refosco F; Pietzsch HJ; Spies H; Uccelli L; Duatti A
    Bioconjug Chem; 2004; 15(3):628-37. PubMed ID: 15149191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glutathione-mediated metabolism of technetium-99m SNS/S mixed ligand complexes: a proposed mechanism of brain retention.
    Nock BA; Maina T; Yannoukakos D; Pirmettis IC; Papadopoulos MS; Chiotellis E
    J Med Chem; 1999 Mar; 42(6):1066-75. PubMed ID: 10090789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of Oxorhenium(V) and Oxotechnetium(V) Complexes That Bind to Amyloid-β Plaques.
    Hayne DJ; White JM; McLean CA; Villemagne VL; Barnham KJ; Donnelly PS
    Inorg Chem; 2016 Aug; 55(16):7944-53. PubMed ID: 27459001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel mixed ligand technetium complexes as 5-HT1A receptor imaging agents.
    León A; Rey A; Mallo L; Pirmettis I; Papadopoulos M; León E; Pagano M; Manta E; Incerti M; Raptopoulou C; Terzis A; Chiotellis E
    Nucl Med Biol; 2002 Feb; 29(2):217-26. PubMed ID: 11823127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel lipophilic amidate oxorhenium and oxotechnetium complexes as potential brain agents: synthesis, characterization and biological evaluation.
    Papadopoulos M; Nock B; Maina T; Pirmettis I; Raptopoulou C; Tasiopoulos A; Troganis A; Kabanos T; Terzis A; Chiotellis E
    J Biol Inorg Chem; 2001 Feb; 6(2):159-65. PubMed ID: 11293409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of oxorhenium(V) and oxotechnetium(V) [SN(R)S/S] mixed ligand complexes containing a phenothiazine moiety on the tridentate SN(R)S ligand.
    Pirmettis I; Patsis G; Pelecanou M; Tsoukalas C; Papadopoulos A; Raptopoulou CP; Terzis A; Papadopoulos M; Chiotellis E
    Bioorg Med Chem Lett; 2001 Jul; 11(14):1859-62. PubMed ID: 11459647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substituted halogenated arylsulfonamides: a new class of sigma receptor binding tumor imaging agents.
    John CS; Lim BB; Vilner BJ; Geyer BC; Bowen WD
    J Med Chem; 1998 Jul; 41(14):2445-50. PubMed ID: 9651150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and biodistribution of a new oxo-technetium-99m bis(aminothiol) complex as a potential melanoma tracer.
    Auzeloux P; Papon J; Pasqualini R; Madelmont JC
    J Med Chem; 2001 Mar; 44(7):1116-21. PubMed ID: 11297457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [99mTc(CO)3]+ and [99mTcO2]+ radiolabeled cyclic melanotropin peptides for melanoma SPECT imaging.
    Zhang X; Teixeira V; Porcal W; Cabral P; Gambini JP; Fernandez M; Gallazzi F; Quinn TP
    Curr Radiopharm; 2014; 7(1):63-74. PubMed ID: 25022516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and comparative in vivo evaluation of
    Vats K; Satpati D; Sharma R; Sarma HD; Banerjee S
    Chem Biol Drug Des; 2017 Mar; 89(3):371-378. PubMed ID: 27561428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization and preliminary evaluation of ester-modified technetium-99m SNS/S mixed ligand complexes as potential brain perfusion agents.
    Tsoukalas C; Papadopoulos MS; Maina T; Pirmettis IC; Nock BA; Raptopoulou C; Terzis A; Chiotellis E
    Nucl Med Biol; 1999 Apr; 26(3):297-304. PubMed ID: 10363801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxotechnetium 99mTcO[SN(R)S][S] complexes as potential 5-HT1A receptor imaging agents.
    Papagiannopoulou D; Pirmettis I; Tsoukalas Ch; Nikoladou L; Drossopoulou G; Dalla C; Pelecanou M; Papadopoulou-Daifotis Z; Papadopoulos M; Chiotellis E
    Nucl Med Biol; 2002 Nov; 29(8):825-32. PubMed ID: 12453592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [99mTc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging.
    Nock B; Nikolopoulou A; Chiotellis E; Loudos G; Maintas D; Reubi JC; Maina T
    Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):247-58. PubMed ID: 12552343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and bioevaluation of technetium-99 m / rhenium labeled phenylquinoxaline derivatives as Tau imaging probes.
    Yang F; Wang K; Zhou K; Dai B; Dai J; Liang Y; Cui M
    Eur J Med Chem; 2019 Sep; 177():291-301. PubMed ID: 31158745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complexes of technetium-99m with tetrapeptides, a new class of 99mTc-labelled agents.
    Vanbilloen HP; Bormans GM; De Roo MJ; Verbruggen AM
    Nucl Med Biol; 1995 Apr; 22(3):325-38. PubMed ID: 7627148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.